Key facts
- Cannumo’s last known valuation is $3.5M (Dec 2025).
- It has raised $1.7M; the latest was Angel (individual) ($1.2M) in Dec 2025.
- Notable investors include Dominykas Jezerys, Mykolas Karpicius, Tadas Burgaila.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Cannumo
- ·The full record, as it builds
Funding rounds
No funding rounds for Cannumo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cannumo
Manufacturer of fermented wellness beverages intended to support gut health through live bacterial cultures. The company develops biologically active drinks made with fermented berries and diverse bacterial strains, enabling health-conscious consumers to improve digestive balance and overall well-being.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Vilnius, Lithuania
- Founded
- 2021
- Employees
- 7
- Website
- cannumo.lt/
- Ownership
- Privately Held (backing)
Cannumo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cannumo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cannumo in its N-PORT filings yet. We sweep new filings monthly.